openPR Logo
Press release

Codex Labs OTC Bia Eczema Relief Lotion Is Awarded Seal of Acceptance from National Eczema Association and Microbiome-Friendly Certification from MyMicrobiome

04-08-2025 11:04 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Codex Labs OTC Bia Eczema Relief Lotion Is Awarded Seal

San Jose, Calif. - April 8th, 2025 - Codex Labs [https://www.codexlabscorp.com/], a Silicon Valley skintech company, announced that its over-the-counter (OTC) Bia Eczema Relief [https://www.codexlabscorp.com/collections/eczema/products/bia-eczema-relief-lotion]Lotion [https://www.codexlabscorp.com/collections/eczema/products/bia-eczema-relief-lotion]has been awarded the Seal of Acceptance by the National Eczema Association (NEA). The NEA Seal of Acceptance Trademark highlights products that avoid ingredients known to irritate and that are suitable for the care of eczema or sensitive skin.

The Bia Eczema Relief Lotion has also achieved Microbiome-friendly certification, according to the MyMicrobiome Standard. It is the first eczema OTC topical to achieve this certification.

"We are thrilled that our products have been recognized as non-irritating for over 30 million Americans who suffer from eczema, as well as microbiome-safe. We remain dedicated to creating solutions that protect and restore the skin barrier while supporting the microbiome," says Dr. Barbara Paldus, Founder and CEO.

The BIA eczema relief lotion leverages the patent-pending BiaComplex 2.0 Trademark , a blend of biotech-made cellular extracts derived from terrestrial and marine plants. This novel combination of actives addresses hydration, skin barrier repair (both increased ceramide and structural protein production and itch reduction in distinct yet synergistically effective ways.

The Bia Eczema Relief Lotion is designed to be used with the Bia [https://www.codexlabscorp.com/collections/eczema/products/bia-unscented-soap] Unscented Soap [https://www.codexlabscorp.com/collections/eczema/products/bia-unscented-soap], the first vegan, MyMicrobiome-certified soap that also carries the NEA Seal of Acceptance. This "Eczema Essentials" set can also be combined with the Antu Skin Barrier Support supplement in a trio that addresses both gut and skin barrier integrity. The supplement provides L-histidine, an amino acid used by the body to produce filaggrin protein and natural moisturization factor to reinforce the skin barrier, as well as a novel antioxidant (M3Plus Trademark ) that helps address gut barrier inflammation and permeability.

This "Ditch the Itch" trio underwent a clinical trial on subjects having mild to moderate eczema (SCORAD = 34.5). The measured improvements in 8 weeks included:

*
93% reduction in eczema score (SCORAD) in 100% of subjects

*
88% reduction of itch in 97% of subjects

*
117% hydration increase in 91% of subjects

*
83% flakiness (desquamation) decrease in 97% of subjects

"The Ditch the Itch set was tested in a clinical study and performed well for managing moderate eczema. It is remarkable to think that these are over-the-counter products, available to everyone without a prescription," stated Dr. Peter Lio, a leading US expert in pediatric eczema and Codex Labs Medical Advisory Board member. He added: "Such clinical results demonstrate the importance of addressing skin conditions with both topicals and ingestibles in an integrative, inside-out approach."

About Codex Labs

Based in Silicon Valley and led by scientist Dr. Barb Paldus, Codex Labs is committed to creating highly effective, clinically proven, microbiome-supporting skin-gut-brain-biome solutions that contain potent, biotech-derived plant-based actives. Our products are focused on restoring/protecting the skin barrier, managing inflammation, and addressing skin conditions associated with aging, acne, eczema and psoriasis. The brand has been heralded by integrative dermatologists and naturopathic doctors for creating the next generation of effective, vegan, cruelty-free and sustainable dermaceutical solutions.

Media Contact
Company Name: Otter Public Relations
Contact Person: Anna Kate Womack
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=codex-labs-otc-bia-eczema-relief-lotion-is-awarded-seal-of-acceptance-from-national-eczema-association-and-microbiomefriendly-certification-from-mymicrobiome]
Phone: 7032323140
City: ORLANDO
State: FL
Country: United States
Website: http://www.otterpr.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Codex Labs OTC Bia Eczema Relief Lotion Is Awarded Seal of Acceptance from National Eczema Association and Microbiome-Friendly Certification from MyMicrobiome here

News-ID: 3961696 • Views:

More Releases from ABNewswire

Retinitis Pigmentosa Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics Inc
Retinitis Pigmentosa Market to Evolve Rapidly Over the Next Decade by 2034, Delv …
The Key Retinitis Pigmentosa Companies in the market include - SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics Inc, Coave Therapeutics, jCyte, Nightstar Therapeutics, ReNeuron, and others. The Retinitis Pigmentosa market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Retinitis Pigmentosa pipeline products will significantly revolutionize the Retinitis Pigmentosa market dynamics. DelveInsight's "Retinitis Pigmentosa Market Insights, Epidemiology,
Leading Travel Agencies Excel in Sandals Resort Bookings and Customer Service
Leading Travel Agencies Excel in Sandals Resort Bookings and Customer Service
Specialized agents deliver exceptional Caribbean vacation experiences for discerning travelers The luxury Caribbean resort market continues to thrive as specialized travel agencies demonstrate exceptional expertise in curating unforgettable Sandals Resort experiences. These dedicated professionals have established themselves as trusted partners for couples seeking premium all-inclusive vacations across the Caribbean's most desirable destinations. Several standout agencies have established themselves as leaders in the Sandals resort booking space, each bringing unique expertise and exceptional
Queen's Destiny, Book One of the Blood Prophecy Series by Barb Jones Delivers A Gripping Supernatural Thriller Where Destiny, Magic, and Ancient Prophecy Collide
Queen's Destiny, Book One of the Blood Prophecy Series by Barb Jones Delivers A …
In Barb Jones' Queen's Destiny, Book One of the Blood Prophecy Series, a young woman's life is upended by a 3,000-year-old prophecy, placing her directly at the center of a battle that has spanned a millennia. Image: https://www.abnewswire.com/upload/2025/08/081638a9cac59f3ec5e1ac3f770f589b.jpg Barb Jones is a literary force to be reckoned with, captivating readers worldwide with her best-selling and award-winning Blood Prophecy and Heaven and Hell series. An acclaimed author in the realms of supernatural thrillers
Benign Prostatic Hyperplasia Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Boehringer Ingelheim, Merck & Co. Inc., Allergan PLC, Astellas
Benign Prostatic Hyperplasia Pipeline 2025: Latest FDA Approvals, Clinical Trial …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Benign Prostatic Hyperplasia pipeline constitutes 10+ key companies continuously working towards developing 10+ Benign Prostatic Hyperplasia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Benign Prostatic Hyperplasia Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/benign-prostatic-hyperplasia-bph-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Benign Prostatic Hyperplasia Market. The

All 5 Releases


More Releases for Bia

Survey: 68% of Companies Still Skip BIA-Experts Warn of Risk
A BPX survey reveals 68% of companies skip Business Impact Assessment, risking disruption, revenue loss, and regulatory non-compliance. Recently, an industry survey conducted by Business Process Xperts (BPX) has disclosed shocking results: 68% of companies are not doing Business Impact Assessment (BIA) as part of their risk management planning ( https://businessprocessxperts.com/business-process-management-bpm-consulting/ ), or continuity planning initiatives. The consequence of this negligence means companies are leaving themselves open to disruptions, loss of
Codex Labs Introduces First Bia OTC: Eczema Relief Lotion
SAN JOSE, CA - Feb 25th, 2025 - Codex Labs (https://www.codexlabscorp.com/), a Silicon Valley skintech company, has launched the first of its Bia over-the-counter (OTC) topicals for eczema management. Bia, meaning "food" in Gaelic, is often paired with "nourishment" in Celtic philosophy. The BIA eczema lotion leverages the patent-pending BiaComplex 2.0 Trademark , a blend of biotech-made cellular extracts derived from terrestrial and marine plants. This novel combination of actives addresses
Hospital BC Introduces Bioelectrical Impedance Analysis (BIA) for Enhanced Patie …
Hospital BC in Tijuana, Mexico, led by Dr. Jalil Illan Fraijo, introduces Bioelectrical Impedance Analysis (BIA) to enhance patient care. BIA measures body composition, offering better insights into fat, muscle, and water mass compared to traditional methods like BMI. This non-invasive technology helps optimize bariatric care by reducing muscle loss risks, ensuring more precise treatment plans, and improving patient outcomes. Tijuana, Mexico - February 19, 2025 - Hospital BC, led by
Cloud based Information Governance Market to Witness Huge Growth by Key Players: …
According to Market Study Report, Cloud based Information Governance Market provides a comprehensive analysis of the Cloud based Information Governance Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5275651 The report provides a comprehensive analysis of company profiles listed below: - Ernst &
07-09-2020 | Health & Medicine
InBody
F45 select InBody as an exclusive global BIA device partner.
A partnership between world leaders in their industries will bring the science-backed InBody BIA devices and technology to F45 members around the world.    InBody and F45 have signed an exclusive deal to provide access to InBody BIA technology to all F45 clubs globally. This partnership will help bring F45 into a position to supply the science-backed InBody technology that is trusted globally to all of its members. After comprehensive testing and comparison analysis
ESPEN 2013: BIA completely accepted by nutritionists
Bioelectrical Impedance Analysis (BIA) is a topical issue in nutrition medicine. That was made clear by the crowds at the seca BIA Workshop “Bioelectrical Impedance Analysis in Malnutrition and Obesity: Meet the Experts” at ESPEN in Leipzig. Nutritionists were eager to hear research results and information about clinical application of BIA directly from the experts. The list of speakers read like a Who’s Who of researchers working in body composition